2014 annual financial data
Amphastar Pharmaceuticals 2014 Operating margin
Direct answer
Operating margin was -8.54%.
Operating income was -17,983,000 USD and net income was -10,699,000 USD.
Operating cash flow was 21,052,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 210,461,000 USD
- Operating income
- -17,983,000 USD
- Net income
- -10,699,000 USD
- Operating cash flow
- 21,052,000 USD